Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples